Article
Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infections.
Antimicrobial agents and chemotherapy - 1 Jan 2004
Miller Keith, O'Neill Alexander John, Chopra Ian
Abstract excerpt
Mutators may present an enhanced risk for the emergence of antibiotic resistance in bacteria during chemotherapy. Using Escherichia coli mutators as a model, we evaluated their ability to develop resistance to antibiotics routinely used for the treatment of urinary tract infections (UTIs). Under conditions that simulate therapeutic drug concentrations in humans, low-level resistance to trimethoprim, gentamicin,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
